This study is researching the weight-loss effects of a new medication to treat obesity. The aim of the study is to evaluate the body weight lowering effects of the new study drug compared with Saxenda, a drug that has previously been used for weight loss. The study drug is shown to induce weight loss which reduces major adverse cardiac events, whilst also conveniently only needing to be administered weekly which aims to promote greater compliance.
To compliment the study drug, the research will also provide counselling on physical activity and diet once or twice a month to aid with weight-loss.
The study would require you to come in for 12 visits over 6 months. Visits will range between 15 mins up to 90 mins each time you come in. Over the course of the study, you will be provided with the study medication which will need to be administered either once per day or once per week depending on your allocated medication. A paper diary will also be provided for participants to make notes regarding the injections.
You will be reimbursed for your time and involvement in the research study.
- Aged between 18 and 70 years
- Must have a BMI ≥30.0 kg/m2 and ≤40.0 kg/m2
- Must not be diagnosed with type 2 or other types of diabetes mellitus